ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IDH Immunodiagnostic Systems Holdings Plc

378.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Holdings Plc LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 378.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Immunodiagnostic Systems Hldgs PLC Transaction in Own Shares (9980J)

05/04/2018 2:16pm

UK Regulatory


Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Immunodiagnostic Systems Charts.

TIDMIDH

RNS Number : 9980J

Immunodiagnostic Systems Hldgs PLC

05 April 2018

Immunodiagnostic Systems Holdings plc

Transaction in Own Shares

05 April 2018

Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets, announces that it has purchased (through Peel Hunt LLP acting as the Company's broker) the following number of its shares of 2p each on the London Stock Exchange. The purchased shares will be held as treasury shares.

The purchases were made pursuant to the buy-back programme announced on 21 June 2017.

 
 Date of purchase:                         05 April 2018 
 Number of shares purchased (aggregated 
  volume):                                 3,318 
 Highest price paid per share (pence):     220 
 Lowest price paid per share (pence):      220 
 Volume weighted average price paid 
  per share (pence):                       220 
 

Following the purchase of these shares, IDS holds 57,099 ordinary shares as treasury shares and the Company's issued share capital (excluding shares held as treasury shares) consists of 29,393,076 shares. All of the shares have equal voting rights. This figure 29,393,076 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases made by Peel Hunt on the Company's behalf is set out in the schedule below.

For further information:

 
 Immunodiagnostic Systems     Tel : +44 (0)191 
  Holdings plc                 519 0660 
 Paul Martin, Group Finance 
  Director 
 
 
 Peel Hunt LLP                Tel : +44 (0)207 
                               418 8900 
 James Steel 
 Oliver Jackson 
 

Schedule of Purchases - Individual Transactions

 
 Number of shares   Transaction price    Time of transaction   Trading venue 
  purchased          (pence per share) 
 3,318              220                  11:56:30              London Stock Exchange 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

POSXELFBVZFFBBE

(END) Dow Jones Newswires

April 05, 2018 09:16 ET (13:16 GMT)

1 Year Immunodiagnostic Systems Chart

1 Year Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

Your Recent History

Delayed Upgrade Clock